Non-high-density lipoprotein cholesterol: why lower is better.

  title={Non-high-density lipoprotein cholesterol: why lower is better.},
  author={Rahul Garg and Chandrasekhar R. Vasamreddy and Roger S. Blumenthal},
  journal={Preventive cardiology},
  volume={8 3},
Recent comparative trials of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors (statins) suggest that lower is better and that reducing low-density lipoprotein cholesterol (LDL-C) levels to below 100 mg/dL can provide additional clinical benefit. Non-high-density lipoprotein cholesterol (non-HDL-C) contains more atherogenic cholesterol than LDL-C and is considered a more accurate measurement of the total amount of atherogenic particles in the circulation. Therefore, the principle that… CONTINUE READING